Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Dya Mx, Inc. announced it raised $140,000 in an initial filing from an offering of $1 Million
PRIVATEFeb 14, 2018•over 8 years ago
Amount Raised
$140,000
Round Type
Pre-Seed
PlymouthHealthcare
Company Information
Company
Endogenex
Location
151 CHESHIRE LANE N, SUITE 400
Plymouth, Minnesota, United States
About
Endogenex is a privately held, clinical-stage company headquartered in Minneapolis, MN. Endogenex was founded in partnership with Mayo Clinic to develop therapies to improve outcomes for people living with type 2 diabetes. Endogenex focuses on the principle that effective treatment for type 2 diabetes can extend beyond pharmaceutical options, correct metabolic function, and help people regain control of their blood glucose levels.
Don't miss Endogenex's next move
Get an email the moment Endogenex raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contacts
Verified contactsChristopher S., Chief Medical Officer hidden hidden